Background <p>Oxygen support is crucial during sedated gastrointestinal endoscopic procedures, as sedation may cause airway collapse, leading to hypoxemia. While nasal cannula (NC) is the most used oxygen delivery method, the procedural oxygen mask (POM) has emerged as an alternative. This study aims to compare the effects of POM and NC on respiratory complications and hemodynamic parameters in patients undergoing sedated endoscopy.</p> Methods <p>This prospective observational study included 350 adult patients undergoing elective endoscopy. Patients were divided into two groups based on patient preference: procedural oxygen mask (POM, n = 200) and nasal cannula (NC, n = 150). Oxygen support was administered using either POM or NC, and hemodynamic and respiratory parameters, including peripheral capillary oxygen saturation (SpO<sub>2</sub>), blood pressure, and heart rate, were monitored throughout the procedure. Respiratory complications, such as hypoxemia (defined SpO<sub>2</sub> &lt; 93%), were also recorded for analysis.</p> Results <p>The POM group showed significantly higher SpO<sub>2</sub> values at 1, 5, 10, and 15&#xa0;min (p &lt; 0.001). Hypoxemia rates were lower in the POM group (2.5%) compared to the NC group (6.7%) (p = 0.028). The POM group also had significantly lower systolic and diastolic blood pressures and a more stable mean arterial pressure (p &lt; 0.001). Recovery time was longer in the POM group (p &lt; 0.001), likely due to deeper sedation levels.</p> Conclusion <p>POM provides superior oxygen support and hemodynamic stability compared to NC, making it a safer option for sedated gastrointestinal endoscopic procedures. Despite older age and higher ASA scores in the POM group, it showed better respiratory outcomes and lower blood pressure fluctuations, demonstrating efficacy in higher-risk patients.</p> Clinical Trials <p><a href="http://www.clinicaltrials.gov">www.clinicaltrials.gov</a>; Registration Number: NCT05684900; Registration Date: 29.11.2022.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Comparison of Procedural Oxygen Mask and Nasal Cannula in Endoscopic Procedures: A Prospective Observational Study

  • Aydogan Celik,
  • Mehmet Yilmaz,
  • Ahmet Yuksek,
  • Sema Candan,
  • Ayse Zeynep Turan Civraz,
  • Merve Yazici Kara,
  • Bedirhan Gunel

摘要

Background

Oxygen support is crucial during sedated gastrointestinal endoscopic procedures, as sedation may cause airway collapse, leading to hypoxemia. While nasal cannula (NC) is the most used oxygen delivery method, the procedural oxygen mask (POM) has emerged as an alternative. This study aims to compare the effects of POM and NC on respiratory complications and hemodynamic parameters in patients undergoing sedated endoscopy.

Methods

This prospective observational study included 350 adult patients undergoing elective endoscopy. Patients were divided into two groups based on patient preference: procedural oxygen mask (POM, n = 200) and nasal cannula (NC, n = 150). Oxygen support was administered using either POM or NC, and hemodynamic and respiratory parameters, including peripheral capillary oxygen saturation (SpO2), blood pressure, and heart rate, were monitored throughout the procedure. Respiratory complications, such as hypoxemia (defined SpO2 < 93%), were also recorded for analysis.

Results

The POM group showed significantly higher SpO2 values at 1, 5, 10, and 15 min (p < 0.001). Hypoxemia rates were lower in the POM group (2.5%) compared to the NC group (6.7%) (p = 0.028). The POM group also had significantly lower systolic and diastolic blood pressures and a more stable mean arterial pressure (p < 0.001). Recovery time was longer in the POM group (p < 0.001), likely due to deeper sedation levels.

Conclusion

POM provides superior oxygen support and hemodynamic stability compared to NC, making it a safer option for sedated gastrointestinal endoscopic procedures. Despite older age and higher ASA scores in the POM group, it showed better respiratory outcomes and lower blood pressure fluctuations, demonstrating efficacy in higher-risk patients.

Clinical Trials

www.clinicaltrials.gov; Registration Number: NCT05684900; Registration Date: 29.11.2022.